Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected
John A. Dean
John is a Managing Director of TM Capital and is responsible for transaction execution across the firm’s healthcare practice, including all aspects of the deal […]
Michael S. Goldman
Michael was a founding partner of TM Capital, joining with his colleagues to establish the firm in 1989. He has been responsible for some of TM Capital’s most complex merger, acquisition, and financing transactions for publicly traded and private client companies, and has served on the Boards of Directors of numerous public and private companies.
Josh Mastracci
Josh Mastracci is a Managing Director at TM Capital and is responsible for transaction execution across the firm’s healthcare practice, including all aspects of the […]
James I. McLaren
James McLaren is a Managing Director of TM Capital and brings his extensive background in the healthcare industry to the firm’s healthcare team. James joined TM […]
Paul R. Smolevitz
Paul Smolevitz is a Managing Director and was a founding partner of TM Capital in 1989. Since then, he has led TM Capital’s execution of […]